Spontaneous Reporting of Adverse Drug Reactions by Consumers in Comparison with Healthcare Professionals in Turkey from 2014 to 2016

Aydinkarahaliloglu, N. Demet; Aykaç, Emel; Atalan, Özge; Demir, Nilcan; Hayran, Mutlu

doi:10.1007/s40290-018-0244-8

Cited by 6 publications

(9 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The number of ADR reports are 2 per 1 million population in Turkey, and below the average of countries with similar socioeconomic levels, which is 27/1 million [17]. Although there is an increase in reporting rate over the years in Turkey, it is still below the average of the abovementioned countries [24].…”

Section: Introductionmentioning

confidence: 99%

Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

Güner

Ekmekçi

2019

Journal of Drug Assessment

119

View full text Add to dashboard Cite

Background: Spontaneous adverse drug reaction (ADR) reports prepared by healthcare professionals (HCPs) are the backbone of collecting post-marketing safety data. However, underreporting is a global problem creating health, economic, and ethical burden.Objectives: To determine the factors limiting ADR reporting rates from the HCPs’ point of view.Methods: A questionnaire containing 43 questions evaluating sociodemographic characteristics, pharmacovigilance knowledge and activities, and prescription behaviors was prepared on “surveymonkey.com.” The link was distributed mainly by professional organizations.Results: Although this survey aimed to reach all HCPs, most of the respondents were physicians and nurses. Of the 259 (69.6%) participants who encountered ADR at least once, only 105 (40.5%) reported ADR. The term “pharmacovigilance” was heard for the first time in this survey by 35.5% (n = 132) of the participants. Only 34.7% (n = 129) of the participants knew where to find the ADR reporting form, and 25.5% (n = 95) had previously filled the form and/or read it. Only 28.5% (n = 106) of the participants were aware of the ADR reporting and monitoring system of their institutions and related professionals. Almost all the participants agreed that pharmacovigilance and ADR reporting training are necessary.Conclusion: The main reason for underreporting is limited pharmacovigilance knowledge of HCPs. Training activities based on the needs and preferences of HCPs and close follow-up by authorities are the main steps to improve pharmacovigilance activities.

show abstract

Section: Introductionmentioning

confidence: 99%

Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

Güner

Ekmekçi

2019

Journal of Drug Assessment

119

View full text Add to dashboard Cite

show abstract

“…In another study aiming to evaluate the awareness of TUFAM among physicians and nurses, conducted in a university hospital in Turkey showed that it was as low as 30% (19). In another survey aiming to evaluate the awareness of PV among nurse and midwifes determined that only 23.3% of the participants could correctly define it (20).Underreporting is a global problem which creates health and ethical burden and our reporting rates are low compared to those in developed countries (9,21).…”

Section: Introductionmentioning

confidence: 98%

A Reflection of Educational Advancements In Undergraduate Medical Education From Pharmacological Perspective

Şavli¹,

Şavli²

2019

MJWBS

View full text Add to dashboard Cite

Advances in technology accompanied by the rapid accumulation of new knowledge force higher education institutions to change the way in which they prepare their graduates for healthcare delivery systems. Medical education administrators in higher education should seek the appropiate curricular revisions that will yield the improvements in the lifelong academic performance of undergraduate medicine students. Adverse drug reactions and medical device incidents may cause "serious health issues" as shown in literature. There is no international standard exists for teaching pharmacovigilance at universities for undergraduate medical, pharmacy, dentistry, nursing and midwifery students. The aim of this review is to raise the awareness of the importance of pharmacovigilance, ecopharmacovigilance and medical device incidents in pharmacology curriculum in higher education and to underline the role of medical academics in encouraging undergraduate students for appropiate reporting of adverse drug reactions and medical device incidents to vigilance systems in accordance with national regulations and also in promoting for proper waste management and safe disposal of pharmaceuticals and personal care products.

show abstract

“…Adverse drug reactions (ADRs) are a leading cause of morbidity and death; moreover, they place a substantial financial burden on healthcare systems worldwide. 1 In fact, ADRs that occur in real-life medical practice are rarely predicted by pre-marketing research data. As a result, the most significant tool for pharmacovigilance (PV) systems for the early detection of an unexpected and severe ADR is post-marketing surveillance.…”

mentioning

confidence: 99%

“…As a result, the most significant tool for pharmacovigilance (PV) systems for the early detection of an unexpected and severe ADR is post-marketing surveillance. 1 , 2 Accordingly, the Uppsala Monitoring Centre (UMC), established under the support of the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM), collects global data on ADRs from 148 participating countries. 3 However, it has been reported that developing countries have a lower ADR reporting rate than developed countries.…”

mentioning

confidence: 99%

“…In Turkey, the low reporting of ADRs is a major problem. 1 , 2 In 1987, Turkey became a member of the WHO–UMC programme, and pharmacovigilance contact points (PCPs) were established under the national PV system following the revised laws in 2005. 3 , 4 According to a global survey, Turkey reported 1,710 ADRs to the WHO–UMC database in 2008, which is only two reports per million of the population per year (hereafter, ‘million/year’).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey

Khan

Karataş

2022

Journal of Taibah University Medical Sciences

View full text Add to dashboard Cite

Spontaneous Reporting of Adverse Drug Reactions by Consumers in Comparison with Healthcare Professionals in Turkey from 2014 to 2016

Cited by 6 publications

References 29 publications

Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

A Reflection of Educational Advancements In Undergraduate Medical Education From Pharmacological Perspective

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey

Contact Info

Product

Resources

About